| 2023-05-04 | -22.3% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2022-05-10 | -20.1% | legal | SEC EDGAR | BHC 8-K: 1.01, 8.01 (SEC Filing) |
| 2022-05-10 | -20.1% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-10-30 | +19.8% | earnings | Seeking Alpha | Bausch Health Companies Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-10-30 | +19.8% | earnings | Seeking Alpha | Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth |
| 2025-10-30 | +19.8% | earnings | Seeking Alpha | Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript |
| 2025-10-30 | +19.8% | earnings | Yahoo Finance | BHC Stock Up on Q3 Earnings Beat, Salix and Solta Drive Sales - Yahoo Finance |
| 2025-10-30 | +19.8% | news | StocksToTrade | Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade |
| 2025-10-30 | +19.8% | legal | TradingView | Bausch Health Companies Inc. SEC 10-Q Report - TradingView |
| 2022-06-24 | +16.6% | legal | SEC EDGAR | BHC 8-K: 5.02 and (SEC Filing) |
| 2022-06-24 | +16.6% | legal | SEC EDGAR | BHC 8-K: 5.02 and 5.07 (SEC Filing) |
| 2025-08-14 | +16.5% | news | Investing.com | Paulson John buys $312 million in Bausch Health (BHC) shares - Investing.com |
| 2021-08-03 | -15.9% | legal | SEC EDGAR | BHC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-08-08 | +15.0% | M&A | Yahoo Finance | Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Yahoo Finance |
| 2024-10-30 | +15.0% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-04-09 | -14.8% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-07-07 | +13.5% | legal | SEC EDGAR | BHC 8-K: 1.01 and (SEC Filing) |
| 2023-07-07 | +13.5% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2025-07-30 | -13.1% | earnings | Seeking Alpha | Bausch Health Companies GAAP EPS of $0.40 beats by $0.36, revenue of $2.53B beats by $40M |
| 2025-07-30 | -13.1% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-02-19 | +13.1% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2022-05-11 | +12.9% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2024-05-02 | -12.8% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-11-28 | +12.7% | earnings | Yahoo Finance | Bausch (BHC) Down 5.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance |
| 2025-11-28 | +12.7% | news | Investing.com | Paulson & co buys $15.6m of Bausch Health (BHC) - Investing.com |
| 2026-01-23 | -12.3% | news | Seeking Alpha | Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor |
| 2026-01-23 | -12.3% | news | Seeking Alpha | Bausch Health falls on phase 3 failure of liver disease complications drug |
| 2026-01-23 | -12.3% | news | Seeking Alpha | Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor (NYSE:BHC) - Seeking Alpha |
| 2026-01-23 | -12.3% | news | Stock Titan | Experimental liver cirrhosis treatment falls short in Bausch RED-C trials - Stock Titan |
| 2026-01-22 | -11.7% | news | Yahoo Finance | A Look At Bausch Health (BHC) Valuation As Shares Show Recent Weak Momentum - Yahoo Finance |
| 2023-02-23 | +11.3% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2022-07-29 | -11.2% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2021-05-04 | -10.2% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2021-05-04 | -10.2% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2022-11-30 | +9.8% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-06-10 | +9.4% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2023-09-18 | -9.2% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-12-01 | +8.9% | news | The Motley Fool | Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Motley Fool |
| 2025-12-01 | +8.9% | news | Benzinga | Why Are Shares Of Bausch Health Up Today? - Bausch Health Companies (NYSE:BHC) - Benzinga |
| 2025-12-01 | +8.9% | news | Stock Titan | Bausch Health (NYSE:BHC) brings Solta Medical distribution in-house in China - Stock Titan |
| 2025-12-01 | +8.9% | news | StocksToTrade | Bausch Health’s Intriguing Market Moves - StocksToTrade |
| 2025-12-01 | +8.9% | news | The Motley Fool | Biggest Stock Movers Today, Dec. 1: BHC, SMR, & More - The Motley Fool |
| 2025-07-31 | -8.6% | earnings | Seeking Alpha | Bausch Health Companies Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-07-31 | -8.6% | earnings | Seeking Alpha | Bausch Health reaffirms 2025 revenue target of $4.95B–$5.1B as debt reduction and pipeline expansion advance |
| 2025-07-31 | -8.6% | earnings | Seeking Alpha | Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript |
| 2025-07-31 | -8.6% | earnings | Yahoo Finance | Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat - Yahoo Finance |
| 2025-06-18 | +8.4% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-11-11 | +8.2% | earnings | Seeking Alpha | Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path |
| 2025-11-11 | +8.2% | earnings | Seeking Alpha | Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path (NYSE:BHC) - Seeking Alpha |
| 2025-10-29 | +7.8% | earnings | Seeking Alpha | Bausch Health rises on 2025 revenue, EBITDA guidance boost, Q3 beats |
| 2025-10-29 | +7.8% | earnings | Seeking Alpha | Bausch Health Companies GAAP EPS of $0.48 beats by $0.10, revenue of $2.68B beats by $50M |
| 2025-10-29 | +7.8% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-10-29 | +7.8% | earnings | Seeking Alpha | Bausch Health rises on 2025 revenue, EBITDA guidance boost, Q3 beats - Seeking Alpha |
| 2025-11-13 | -7.8% | news | Yahoo Finance | Bausch Health Companies Inc. (BHC) Announces the Commercial Expansion of OraPharma into Canada and Puerto Rico - Yahoo Finance |
| 2026-03-31 | +7.3% | news | Insider Monkey | What Makes Bausch Health (BHC) Appear So Attractive |
| 2026-03-31 | +7.3% | news | PR Newswire | Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 |
| 2026-03-31 | +7.3% | earnings | Stock Titan | After the close, Bausch Health will detail Q1 results on April 29 - Stock Titan |
| 2026-03-31 | +7.3% | news | Yahoo Finance | What Makes Bausch Health (BHC) Appear So Attractive - Yahoo Finance |
| 2022-11-03 | +7.1% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-08-15 | +7.0% | news | Seeking Alpha | Bausch Health rises after $300M worth insider purchase (update) |
| 2025-08-15 | +7.0% | legal | SEC EDGAR | BHC 8-K: 1.02, 5.02, 7.01 (SEC Filing) |
| 2025-08-15 | +7.0% | M&A | Quiver Quantitative | Bausch Health Companies Stock (BHC) Opinions on Insider Buying and Acquisition News - Quiver Quantitative |
| 2025-08-15 | +7.0% | news | Yahoo Finance | Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes - Yahoo Finance |
| 2025-08-15 | +7.0% | news | Seeking Alpha | Bausch Health stock rises on insider purchase (BHC:NYSE) - Seeking Alpha |
| 2025-08-15 | +7.0% | news | Investing.com | Paulson Capital increases stake in Bausch Health to 19.13% - Investing.com |
| 2025-07-29 | -6.9% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-07-29 | -6.9% | M&A | PR Newswire | Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - PR Newswire |
| 2026-01-08 | -6.9% | news | AD HOC NEWS | Bausch Health Companies: Volatile Recovery Story Tests Investor Patience - AD HOC NEWS |
| 2025-12-03 | +6.5% | M&A | GuruFocus | John Paulson's Strategic Acquisition in Bausch Health Companies Inc. - GuruFocus |
| 2026-01-15 | -6.5% | news | Seeking Alpha | Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference |
| 2026-01-15 | -6.5% | news | Seeking Alpha | Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-15 | -6.5% | news | Seeking Alpha | Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Seeking Alpha |
| 2025-11-14 | -6.5% | earnings | Seeking Alpha | Carl Icahn's top Q3 moves include new stake in EchoStar, exiting Bausch Health |
| 2025-11-14 | -6.5% | news | Yahoo Finance | John Paulson's Strategic Move: Significant Increase in Bausch Health Companies Inc. - Yahoo Finance |
| 2022-04-28 | -6.3% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.02, 8.01 (SEC Filing) |
| 2025-08-12 | +6.2% | news | Seeking Alpha | Why Bausch Health Stock Surged By Nearly 20% |
| 2025-08-12 | +6.2% | news | Seeking Alpha | Why Bausch Health Stock Surged By Nearly 20% (NYSE:BHC) - Seeking Alpha |
| 2025-08-12 | +6.2% | M&A | PR Newswire | DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - PR Newswire |
| 2025-04-15 | +6.2% | legal | SEC EDGAR | BHC 8-K: 1.01, 3.03, 7.01 (SEC Filing) |
| 2025-08-18 | -6.0% | news | Yahoo Finance | Bausch Health (BHC) Climbs 45% on Insider Buying - Yahoo Finance |
| 2026-01-02 | +5.6% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2021-11-02 | -5.5% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-03-25 | -5.4% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2026-03-03 | -5.2% | executive | Stock Titan | Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan |
| 2026-03-03 | -5.2% | executive | Stock Titan | Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan |
| 2026-03-03 | -5.2% | news | Stock Titan | Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan |
| 2026-03-03 | -5.2% | news | Stock Titan | Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan |
| 2025-10-28 | -5.2% | earnings | Seeking Alpha | Bausch Health Companies Q3 2025 Earnings Preview |
| 2025-04-19 | -5.1% | news | Yahoo Finance | Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in? - Yahoo Finance |
| 2022-10-04 | +5.0% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-08-09 | -4.9% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2026-01-21 | -4.9% | earnings | Stock Titan | Feb. 18: Bausch Health to detail Q4 and 2025 results live - Stock Titan |
| 2025-09-16 | -4.6% | M&A | Yahoo Finance | Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis - Yahoo Finance |
| 2025-04-30 | -4.6% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-06-16 | -4.3% | news | Seeking Alpha | Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha |
| 2026-04-21 | -4.2% | earnings | MarketBeat | Bausch Health Cos Inc. (NYSE:BHC) Given Average Rating of "Reduce" by Brokerages - MarketBeat |
| 2026-04-09 | +4.2% | earnings | MarketBeat | JPMorgan Chase & Co. Sells 242,608 Shares of Bausch Health Cos Inc. $BHC - MarketBeat |
| 2026-01-26 | -4.1% | news | Yahoo Finance | Down 17.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Bausch (BHC) - Yahoo Finance |
| 2023-11-02 | +4.1% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | -3.9% | earnings | Motley Fool | Bausch Health (BHC) Q3 2024 Earnings Transcript |
| 2026-04-22 | -3.9% | earnings | MarketBeat | Bausch Health Cos (BHC) Projected to Post Earnings on Wednesday - MarketBeat |
| 2026-04-22 | -3.9% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | BauschHealth (BHC) Stock: Entry Opportunity Analysis | Bausch Health Companies Inc. posts 13.9% EPS miss - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-08-17 | -3.8% | news | TradingView | BHC Stock Price and Chart — TSX:BHC - TradingView |
| 2025-08-16 | -3.8% | earnings | simplywall.st | Improved Revenues Required Before Bausch Health Companies Inc. (NYSE:BHC) Stock's 30% Jump Looks Justified - simplywall.st |
| 2024-02-22 | +3.7% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2022-09-15 | -3.7% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2026-04-02 | -3.6% | news | Stock Titan | Bausch Health (NYSE: BHC) director receives 5,946 RSUs for board service - Stock Titan |
| 2026-04-02 | -3.6% | news | Stock Titan | [Form 4] Bausch Health Companies Inc. Insider Trading Activity - Stock Titan |
| 2026-04-02 | -3.6% | news | Stock Titan | John Paulson receives 11,574 Bausch Health (NYSE: BHC) RSUs as fees - Stock Titan |
| 2024-08-01 | -3.4% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2022-06-03 | -3.1% | legal | SEC EDGAR | BHC 8-K: 5.02 (SEC Filing) |
| 2025-09-09 | -3.0% | news | simplywall.st | Bausch Health (NYSE:BHC): Evaluating Valuation as Shares Surge Without Clear Catalyst - simplywall.st |
| 2026-03-04 | -2.9% | news | simplywall.st | Potential Bausch + Lomb Separation Reframes Bausch Health - simplywall.st |
| 2025-06-27 | +2.9% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2022-09-12 | +2.8% | legal | SEC EDGAR | BHC 8-K: 5.02 (SEC Filing) |
| 2022-09-28 | -2.8% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2022-01-18 | -2.7% | legal | SEC EDGAR | BHC 8-K: 2.04, 8.01 (SEC Filing) |
| 2026-02-17 | +2.7% | earnings | Seeking Alpha | Bausch Health Companies Q4 2025 Earnings Preview |
| 2026-03-02 | -2.5% | legal | SEC EDGAR | BHC 8-K: 5.02 (SEC Filing) |
| 2026-03-02 | -2.5% | news | Stock Titan | Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan |
| 2026-03-02 | -2.5% | news | Stock Titan | Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan |
| 2026-03-02 | -2.5% | news | Kalkine Media | Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media |
| 2025-10-31 | +2.5% | news | Seeking Alpha | Why Bausch Health Is A Buy After Rising 10% On Third Quarter Results |
| 2025-10-31 | +2.5% | news | Seeking Alpha | Why Bausch Health Is A Buy After Rising 10% On Third Quarter Results - Seeking Alpha |
| 2025-07-10 | -2.5% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-12-29 | -2.4% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-12-29 | -2.4% | earnings | 24/7 Wall St. | 2 Strong Mid-Cap Growth Stocks Dan Loeb Bought in Q3 - 24/7 Wall St. |
| 2025-11-24 | +2.4% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2026-01-25 | -2.4% | earnings | StocksToTrade | Bausch Health Faces Setback as Phase 3 Trials Miss Targets - StocksToTrade |
| 2026-01-24 | -2.4% | executive | StocksToTrade | Bausch Health Faces Market Pressure as Phase 3 Trials Disappoint - StocksToTrade |
| 2025-08-21 | -2.3% | news | 24/7 Wall St. | Insider Buys Top $333 Million as Icahn Exits Bausch Health Stake - 24/7 Wall St. |
| 2021-06-21 | -2.3% | legal | SEC EDGAR | BHC 8-K: 5.02 and (SEC Filing) |
| 2026-03-26 | +2.3% | news | PR Newswire | Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program |
| 2024-07-19 | +2.2% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-21 | -2.2% | legal | SEC EDGAR | BHC 8-K: 1.01 and (SEC Filing) |
| 2026-04-06 | -2.2% | news | Cổng thông tin điện tử tỉnh Lào Cai | Should I Sell BauschHealth (BHC) Stock Now | Price at $5.38, Up 0.47% - Crowd Signals - Cổng thông tin điện tử tỉnh Lào Cai |
| 2023-08-03 | -2.2% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2025-06-14 | -2.1% | news | Yahoo Finance | Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - Yahoo Finance |
| 2026-03-20 | +2.1% | earnings | Zacks | Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound? |
| 2026-03-20 | +2.1% | earnings | Yahoo Finance | Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance |
| 2021-05-25 | +2.0% | legal | SEC EDGAR | BHC 8-K: 2.04, 8.01 (SEC Filing) |
| 2025-12-24 | -2.0% | news | Yahoo Finance | Bausch Health (BHC) Is Up 5.3% After US$1.6 Billion Debt Exchange - Has The Bull Case Changed? - Yahoo Finance |
| 2025-05-07 | -2.0% | news | Yahoo Finance | Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - Yahoo Finance |
| 2026-02-06 | +2.0% | news | Yahoo Finance | Bausch Health (BHC) Announces Global Phase 3 RED-C Clinical Program Results - Yahoo Finance |
| 2026-02-26 | -1.9% | earnings | Yahoo Finance | Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance |
| 2025-12-23 | +1.9% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-09-19 | -1.9% | news | Yahoo Finance | Bausch Health Companies Inc. (BHC): A Bull Case Theory - Yahoo Finance |
| 2021-09-30 | +1.7% | legal | SEC EDGAR | BHC 8-K: 5.02 (SEC Filing) |
| 2022-05-31 | -1.7% | legal | SEC EDGAR | BHC 8-K: 5.02 (SEC Filing) |
| 2025-07-15 | +1.7% | news | simplywall.st | In the wake of Bausch Health Companies Inc.'s (NYSE:BHC) latest US$196m market cap drop, institutional owners may be forced to take severe actions - simplywall.st |
| 2026-04-14 | -1.7% | expansion | PR Newswire | Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering |
| 2026-04-14 | -1.7% | news | Stock Titan | French skin cream sold since 1971 is now available online in the U.S. - Stock Titan |
| 2022-02-23 | -1.6% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2026-02-23 | -1.5% | news | Yahoo Finance | Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Yahoo Finance |
| 2026-02-23 | -1.5% | earnings | simplywall.st | The Bull Case For Bausch Health (BHC) Could Change Following Mixed 2025 Results And 2026 Outlook Guidance - simplywall.st |
| 2026-02-23 | -1.5% | news | Stock Titan | New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan |
| 2025-09-23 | -1.5% | legal | Seeking Alpha | Bausch, Teva face lawsuit for delay in generic version of Xifaxan |
| 2024-02-01 | -1.5% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-02-19 | -1.4% | earnings | Seeking Alpha | How Bausch Health's Turnaround Progressed In Q4 2025 |
| 2026-02-19 | -1.4% | earnings | Seeking Alpha | Bausch Health Companies Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-19 | -1.4% | earnings | Seeking Alpha | Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China |
| 2026-02-19 | -1.4% | earnings | Seeking Alpha | Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript |
| 2026-02-19 | -1.4% | earnings | Seeking Alpha | How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha |
| 2026-02-19 | -1.4% | earnings | TradingView | BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - TradingView |
| 2026-02-19 | -1.4% | earnings | Finviz | BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Finviz |
| 2026-02-19 | -1.4% | news | Stock Titan | The gum disease antibiotic dentists have used for 25 years, explained - Stock Titan |
| 2023-06-30 | -1.4% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-07-24 | +1.3% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-15 | +1.3% | legal | SEC EDGAR | BHC 8-K: 5.02 (SEC Filing) |
| 2022-04-04 | +1.2% | legal | SEC EDGAR | BHC 8-K: 8.01 (SEC Filing) |
| 2026-02-18 | -1.2% | earnings | Seeking Alpha | Bausch Health declines on Q4 profit miss |
| 2026-02-18 | -1.2% | earnings | Seeking Alpha | Bausch Health reports Q4 results |
| 2026-02-18 | -1.2% | legal | SEC EDGAR | BHC 8-K: 2.02 and (SEC Filing) |
| 2026-02-18 | -1.2% | news | PR Newswire | BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS - PR Newswire |
| 2026-02-18 | -1.2% | earnings | Investing.com | Bausch Health shares fall after significant Q4 earnings miss - Investing.com |
| 2026-02-07 | +1.2% | news | Yahoo Finance | The Bull Case For Bausch Health Companies (BHC) Could Change Following Failed Xifaxan RED-C Trials Learn Why - Yahoo Finance |
| 2022-08-22 | -1.2% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2026-02-27 | -1.1% | earnings | Simply Wall St. | Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? |
| 2026-02-27 | -1.1% | news | simplywall.st | Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - simplywall.st |
| 2026-02-27 | -1.1% | news | Stock Titan | Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan |
| 2026-02-27 | -1.1% | executive | Stock Titan | Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan |
| 2025-11-27 | +1.1% | news | Yahoo Finance | The Bull Case for Bausch Health (BHC) Could Change Following Debt Exchange and Maturity Extension Initiative - Yahoo Finance |
| 2021-06-08 | -1.0% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03, 8.01 (SEC Filing) |
| 2023-03-01 | -1.0% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-09-13 | +1.0% | legal | SEC EDGAR | BHC 8-K: 8.01 (SEC Filing) |
| 2023-09-29 | -0.9% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.01, 2.03 (SEC Filing) |
| 2023-09-29 | -0.9% | legal | SEC EDGAR | BHC 8-K: 5.02 and (SEC Filing) |
| 2023-09-11 | -0.9% | legal | SEC EDGAR | BHC 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-03-19 | +0.9% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-09-11 | +0.7% | news | Seeking Alpha | Bausch Health: Repricing Continues As Deleveraging Gains Traction |
| 2025-09-11 | +0.7% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2025-09-11 | +0.7% | M&A | PR Newswire | Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio - PR Newswire |
| 2025-09-11 | +0.7% | news | Seeking Alpha | Bausch Health: Repricing Continues As Deleveraging Gains Traction (NYSE:BHC) - Seeking Alpha |
| 2025-05-29 | -0.7% | news | Yahoo Finance | With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - Yahoo Finance |
| 2022-01-27 | -0.7% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2022-03-31 | +0.7% | legal | SEC EDGAR | BHC 8-K: 1.01 and (SEC Filing) |
| 2022-02-10 | +0.6% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2026-03-24 | -0.6% | news | Zacks | Is the Options Market Predicting a Spike in Bausch Health Stock? |
| 2026-03-24 | -0.6% | news | Zacks Investment Research | Is the Options Market Predicting a Spike in Bausch Health Stock? - Zacks Investment Research |
| 2026-02-24 | +0.6% | earnings | GlobeNewswire | OTC Artificial Tears Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033 |
| 2026-02-24 | +0.6% | earnings | GlobeNewswire | Vision Care Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033 |
| 2026-02-24 | +0.6% | news | DirectorsTalk Interviews | Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews |
| 2025-12-09 | -0.6% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2023-09-14 | -0.6% | legal | SEC EDGAR | BHC 8-K: 8.01 (SEC Filing) |
| 2025-10-12 | -0.5% | news | Yahoo Finance | Assessing Bausch Health Companies (NYSE:BHC) Valuation After Recent Share Price Volatility - Yahoo Finance |
| 2026-04-17 | +0.5% | earnings | Eastern Progress | Bausch Health (BHC) Q4 Earnings Lag Estimates - Eastern Progress |
| 2025-12-02 | -0.5% | news | Seeking Alpha | Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript |
| 2025-12-02 | -0.5% | news | Yahoo Finance | Is There Now an Opportunity in Bausch Health Companies After Recent Debt Restructuring Developments? - Yahoo Finance |
| 2024-11-01 | +0.4% | legal | SEC EDGAR | BHC 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-02-03 | -0.4% | news | The Motley Fool | Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention - The Motley Fool |
| 2022-01-13 | +0.4% | legal | SEC EDGAR | BHC 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-18 | +0.4% | news | AD HOC NEWS | Bausch Health Companies stock (CA0717341071): Why its ophthalmology and gastroenterology segments ma - AD HOC NEWS |
| 2026-03-01 | +0.3% | news | simplywall.st | Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - simplywall.st |
| 2026-03-01 | +0.3% | news | AD HOC NEWS | Bausch Health Stock: Why BHC Just Spiked And What It Signals Now - AD HOC NEWS |
| 2025-12-12 | -0.2% | legal | SEC EDGAR | BHC 8-K: 8.01 and (SEC Filing) |
| 2026-01-13 | +0.2% | news | Seeking Alpha | Bausch Health sets 2025 outlook at the higher end of the prior range |
| 2026-01-13 | +0.2% | legal | SEC EDGAR | BHC 8-K: 2.02 and 7.01 (SEC Filing) |
| 2026-01-13 | +0.2% | news | Seeking Alpha | Bausch Health reaffirms 2025 outlook (BHC:NYSE) - Seeking Alpha |
| 2026-02-01 | -0.1% | news | Yahoo Finance | Has The Market Gone Too Far In Marking Down Bausch Health (BHC) Shares? - Yahoo Finance |
| 2021-10-21 | -0.1% | legal | SEC EDGAR | BHC 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-26 | — | news | MSN | Bausch Health rises after $300M worth insider purchase (update) - MSN |